ABSCF
Price
$1.26
Change
-$0.34 (-21.25%)
Updated
Jun 6 closing price
Capitalization
96.33M
AGYTF
Price
$0.09
Change
-$0.00 (-0.00%)
Updated
Jul 21 closing price
Capitalization
560.9M
Interact to see
Advertisement

ABSCF vs AGYTF

Header iconABSCF vs AGYTF Comparison
Open Charts ABSCF vs AGYTFBanner chart's image
AB Science, Paris
Price$1.26
Change-$0.34 (-21.25%)
Volume$400
Capitalization96.33M
Allergy Therapeutics
Price$0.09
Change-$0.00 (-0.00%)
Volume$300
Capitalization560.9M
ABSCF vs AGYTF Comparison Chart in %
Loading...
ABSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSCF vs. AGYTF commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSCF is a Hold and AGYTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (ABSCF: $1.26 vs. AGYTF: $0.09)
Brand notoriety: ABSCF and AGYTF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ABSCF: 100% vs. AGYTF: 54%
Market capitalization -- ABSCF: $96.33M vs. AGYTF: $560.9M
ABSCF [@Pharmaceuticals: Generic] is valued at $96.33M. AGYTF’s [@Pharmaceuticals: Generic] market capitalization is $560.9M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.78B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSCF’s FA Score shows that 1 FA rating(s) are green whileAGYTF’s FA Score has 1 green FA rating(s).

  • ABSCF’s FA Score: 1 green, 4 red.
  • AGYTF’s FA Score: 1 green, 4 red.
According to our system of comparison, AGYTF is a better buy in the long-term than ABSCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSCF’s TA Score shows that 2 TA indicator(s) are bullish.

  • ABSCF’s TA Score: 2 bullish, 0 bearish.

Price Growth

ABSCF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while AGYTF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.87%. For the same industry, the average monthly price growth was +11.08%, and the average quarterly price growth was +76.49%.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.87% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGYTF($561M) has a higher market cap than ABSCF($96.3M). AGYTF YTD gains are higher at: 63.462 vs. ABSCF (40.000).
ABSCFAGYTFABSCF / AGYTF
Capitalization96.3M561M17%
EBITDAN/AN/A-
Gain YTD40.00063.46263%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ABSCF vs AGYTF: Fundamental Ratings
ABSCF
AGYTF
OUTLOOK RATING
1..100
3830
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
90
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
8443
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABSCF's Valuation (31) in the null industry is somewhat better than the same rating for AGYTF (90). This means that ABSCF’s stock grew somewhat faster than AGYTF’s over the last 12 months.

ABSCF's Profit vs Risk Rating (100) in the null industry is in the same range as AGYTF (100). This means that ABSCF’s stock grew similarly to AGYTF’s over the last 12 months.

AGYTF's SMR Rating (94) in the null industry is in the same range as ABSCF (100). This means that AGYTF’s stock grew similarly to ABSCF’s over the last 12 months.

AGYTF's Price Growth Rating (43) in the null industry is somewhat better than the same rating for ABSCF (84). This means that AGYTF’s stock grew somewhat faster than ABSCF’s over the last 12 months.

AGYTF's P/E Growth Rating (6) in the null industry is significantly better than the same rating for ABSCF (100). This means that AGYTF’s stock grew significantly faster than ABSCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABSCFAGYTF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
15%
Bullish Trend 2 days ago
26%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
14%
Bullish Trend 2 days ago
24%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ABSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGGIX65.48N/A
N/A
Gabelli Global Growth I
PLJMX59.41N/A
N/A
Putnam Research R6
NWABX33.80N/A
N/A
Nationwide R6
LMGPX76.72N/A
N/A
ClearBridge International Growth IS
WQAIX12.31N/A
N/A
Westwood Quality AllCap Institutional

ABSCF and

Correlation & Price change

A.I.dvisor tells us that ABSCF and ALID have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABSCF and ALID's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSCF
1D Price
Change %
ABSCF100%
N/A
ALID - ABSCF
16%
Poorly correlated
N/A
ORGO - ABSCF
5%
Poorly correlated
-4.50%
AGYTF - ABSCF
1%
Poorly correlated
N/A
ARSUF - ABSCF
1%
Poorly correlated
N/A
APNHF - ABSCF
1%
Poorly correlated
N/A
More

AGYTF and

Correlation & Price change

A.I.dvisor tells us that AGYTF and SGIOF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGYTF and SGIOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGYTF
1D Price
Change %
AGYTF100%
N/A
SGIOF - AGYTF
25%
Poorly correlated
N/A
SDZXF - AGYTF
20%
Poorly correlated
N/A
PRFX - AGYTF
11%
Poorly correlated
+2.96%
APNHY - AGYTF
4%
Poorly correlated
-1.01%
ORGO - AGYTF
3%
Poorly correlated
-4.50%
More